MarketCap
Facebook
X
Telegram
Inspire Medical Systems Net Income | INSP
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Inspire Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145 M | 53.5 M | -21.2 M | -44.9 M | -42 M | -57.2 M | -33.2 M | -21.8 M | -17.5 M | -18.5 M | -21.3 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 145 M | -57.2 M | -7.16 M |
Quarterly Net Income Inspire Medical Systems
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 314 K | -11.3 M | 9.93 M | -3.59 M | 2.99 M | - | 18.5 M | 9.79 M | -10 M | - | -8.54 M | -12 M | -15.4 M | - | -16.8 M | -14.5 M | -16.7 M | - | -10.3 M | -13.1 M | -16.2 M | -7.48 M | -10.4 M | -23.1 M | -16.2 M | -9.08 M | -8.25 M | -7.65 M | -8.27 M | -4.78 M | -4.69 M | -5.86 M | -6.5 M | -4.25 M | -4.02 M | -4.76 M | -4.48 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.5 M | -23.1 M | -7.17 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Medical devices industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Inari Medical
NARI
|
-1.64 M | - | - | $ 4.23 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
-70.8 M | $ 5.88 | 2.46 % | $ 795 M | USA |
 |
Abbott Laboratories
ABT
|
6.52 B | $ 103.03 | 1.02 % | $ 179 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-6.09 M | - | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
-20.6 M | - | -13.19 % | $ 166 K | USA |
 |
Align Technology
ALGN
|
410 M | $ 152.58 | 1.17 % | $ 11.1 B | USA |
 |
Conformis
CFMS
|
-50.5 M | - | - | $ 16.4 M | USA |
 |
Apyx Medical Corporation
APYX
|
-11.2 M | $ 2.93 | 0.86 % | $ 120 M | USA |
 |
Alphatec Holdings
ATEC
|
-143 M | $ 10.8 | 2.03 % | $ 1.62 B | USA |
 |
AxoGen
AXGN
|
-15.7 M | $ 43.52 | 3.23 % | $ 2 B | USA |
 |
Cutera
CUTR
|
-57.2 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-157 M | - | - | $ 10.2 M | USA |
 |
Medigus Ltd.
MDGS
|
4.05 M | - | 10.28 % | $ 55.5 M |  Israel |
 |
Nemaura Medical
NMRD
|
-14.1 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
Neovasc
NVCN
|
-24.9 M | - | - | $ 111 M |  Canada |
 |
Sientra
SIEN
|
-22 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
-55.7 M | - | - | $ 1.07 B | USA |
 |
Surgalign Holdings
SRGA
|
-54.6 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
147 M | - | - | $ 12.3 B | USA |
 |
ThermoGenesis Holdings
THMO
|
-18.9 M | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
-62 M | - | 3.55 % | $ 7.96 M | USA |
 |
Viveve Medical
VIVE
|
-22 M | - | -15.35 % | $ 1.71 M | USA |
 |
ViewRay
VRAY
|
-107 M | - | 1.54 % | $ 468 M | USA |
 |
Titan Medical
TMDI
|
-14.9 M | - | -26.32 % | $ 19.6 M | Canada |
 |
Natus Medical Incorporated
NTUS
|
13.2 M | - | 1.94 % | $ 1.05 B | USA |
 |
Acutus Medical
AFIB
|
-9.55 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cardiovascular Systems
CSII
|
-36.9 M | - | 0.15 % | $ 844 M | USA |
 |
Invacare Corporation
IVC
|
-20.6 M | - | - | $ 24.7 M | USA |
 |
NuVasive
NUVA
|
40.4 M | - | - | $ 2.07 B | USA |
 |
SmileDirectClub
SDC
|
-86.4 M | - | -53.45 % | $ 9.71 M | USA |
 |
Bruker Corporation
BRKR
|
-8.3 M | $ 52.35 | 0.19 % | $ 7.95 B | USA |
 |
Boston Scientific Corporation
BSX
|
2.89 B | $ 44.87 | 4.45 % | $ 66.4 B | USA |
 |
Accuray Incorporated
ARAY
|
-49.2 M | $ 0.25 | 0.44 % | $ 30.7 M | USA |
 |
Bio-Rad Laboratories
BIO
|
760 M | $ 369.1 | 0.09 % | $ 10.1 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-638 K | $ 8.3 | 3.49 % | $ 605 M | Israel |
 |
ClearPoint Neuro
CLPT
|
-25.5 M | $ 13.52 | 0.18 % | $ 383 M | USA |
 |
CONMED Corporation
CNMD
|
47.1 M | $ 46.61 | 0.63 % | $ 1.45 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-8.2 M | $ 5.91 | 0.63 % | $ 368 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-18.6 M | - | - | $ 1.77 B | USA |
 |
Delcath Systems
DCTH
|
2.7 M | $ 16.32 | 2.58 % | $ 585 M | USA |
 |
Electromed
ELMD
|
11.3 M | $ 26.39 | 0.4 % | $ 218 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-51.1 M | $ 71.54 | 0.85 % | $ 2.12 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
1.07 B | $ 85.31 | 1.11 % | $ 49.9 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-12.3 M | - | -5.86 % | $ 30.6 M | USA |
 |
Globus Medical
GMED
|
538 M | $ 75.29 | 1.42 % | $ 10.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
-40.9 M | $ 2.21 | 0.23 % | $ 48.7 M | USA |
 |
Inogen
INGN
|
22.7 M | $ 5.27 | 0.09 % | $ 140 M | USA |
 |
InMode Ltd.
INMD
|
93.8 M | $ 14.87 | 0.2 % | $ 961 M | Israel |
 |
IRIDEX Corporation
IRIX
|
-4.44 M | $ 0.66 | 0.74 % | $ 11.2 M | USA |